Application
SNX25 Antibody (Center) western blot analysis in Jurkat cell line lysates (35ug/lane).This demonstrates the SNX25 antibody detected the SNX25 protein (arrow).Application
SNX25 Antibody (Center) flow cytometric analysis of Jurkat cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated donkey-anti-rabbit secondary antibodies were used for the analysis.| Product Name | SNX25 Antibody (Center) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | SNX25; Sorting nexin-25 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBFC |
| WB:1:100~500 FC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Alternative Names | SNX25 Sorting nexin-25 |
|---|---|
| Molecular Weight(MW) | 97945 Da |
| Function | May be involved in several stages of intracellular trafficking (By similarity) |
| Tissue Specificity | This SNX25 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 398-426 amino acids from the Central region of human SNX25. |
| Cellular Localization | Endosome membrane; Peripheral membrane protein. Note=Detected in endosome-derived secreted vesicles (exosomes) from malignant pleural effusions |
| Entrez Gene | 83891 |
|---|---|
| Nucleotide Accession | NP_114159.2 |
Application
SNX25 Antibody (Center) western blot analysis in Jurkat cell line lysates (35ug/lane).This demonstrates the SNX25 antibody detected the SNX25 protein (arrow).
Application
SNX25 Antibody (Center) flow cytometric analysis of Jurkat cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated donkey-anti-rabbit secondary antibodies were used for the analysis.| Application Notes | WB:1:100~500 FC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
